ZA200306124B - Method of treating of demyelinating diseases or conditions. - Google Patents

Method of treating of demyelinating diseases or conditions.

Info

Publication number: ZA200306124B
Authority: ZA; South Africa
Prior art keywords: treating; conditions; demyelinating diseases; demyelinating; diseases
Prior art date: 2001-02-15

Application number

ZA200306124A

Other languages

English (en)

Inventor

Craig P Smith

Margaret Petty

Michel P Rathbone

David Rampe

Original Assignee

Aventis Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-15

Filing date

2003-08-07

Publication date

2004-11-08

2003-08-07 Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc

2004-11-08 Publication of ZA200306124B publication Critical patent/ZA200306124B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

ZA200306124A 2001-02-15 2003-08-07 Method of treating of demyelinating diseases or conditions. ZA200306124B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US26884601P	2001-02-15	2001-02-15

Publications (1)

Publication Number	Publication Date
ZA200306124B true ZA200306124B (en)	2004-11-08

Family

ID=23024747

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200306124A ZA200306124B (en)	2001-02-15	2003-08-07	Method of treating of demyelinating diseases or conditions.

Country Status (39)

Country	Link
US (10)	US6967210B2 (xx)
EP (1)	EP1368031A2 (xx)
JP (3)	JP2004518711A (xx)
KR (3)	KR20090005254A (xx)
CN (2)	CN1529598A (xx)
AP (1)	AP1749A (xx)
AR (1)	AR035750A1 (xx)
AU (3)	AU2002247200B9 (xx)
BR (1)	BR0207272A (xx)
CA (1)	CA2438712A1 (xx)
CO (1)	CO5390085A1 (xx)
CR (1)	CR7023A (xx)
CZ (1)	CZ20032172A3 (xx)
EA (2)	EA012409B1 (xx)
EC (1)	ECSP024218A (xx)
EE (1)	EE200300363A (xx)
GB (1)	GB0119435D0 (xx)
HK (1)	HK1080361B (xx)
HR (1)	HRP20030652A2 (xx)
HU (1)	HUP0303203A3 (xx)
IL (2)	IL157341A0 (xx)
MA (1)	MA26152A1 (xx)
ME (1)	MEP21208A (xx)
MX (1)	MXPA03006110A (xx)
MY (1)	MY157745A (xx)
NO (1)	NO20033622L (xx)
NZ (4)	NZ527011A (xx)
OA (1)	OA12549A (xx)
PA (1)	PA8540101A1 (xx)
PE (1)	PE20040175A1 (xx)
PL (1)	PL363638A1 (xx)
SG (1)	SG134170A1 (xx)
SK (1)	SK10392003A3 (xx)
TR (4)	TR200800691T2 (xx)
TW (1)	TWI325319B (xx)
UA (2)	UA80394C2 (xx)
WO (1)	WO2002064126A2 (xx)
YU (1)	YU62903A (xx)
ZA (1)	ZA200306124B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0119435D0 (en) *	2001-02-15	2001-10-03	Aventis Pharm Prod Inc	Method of treating of demyelinating diseases or conditions
KR20050084445A (ko) *	2002-12-20	2005-08-26	다이노젠 파마세우티컬스, 인코포레이티드	α₂δ 서브유닛 칼슘 채널 모듈레이터를 이용한 무통증방광 질환의 치료방법
EP1589959A2 (en) *	2003-01-30	2005-11-02	Dynogen Pharmaceuticals Inc.	Methods of treating lower urinary tract disorders using sodium channel modulators
ES2275229T3 (es) *	2003-03-21	2007-06-01	Dynogen Pharmaceuticals, Inc.	Metodos para el tratamiento de desordenes del tracto urinario iferior utilizando antimuscarinos y moduladores de la subunidad alfa-2-delta del canal de calcio.
GT200500063A (es) *	2004-04-01	2005-10-14		Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
GB0510164D0 (en) *	2005-04-28	2005-06-22	Paradigm Therapeutics Ltd	Ion channel
FR2892021B1 (fr) *	2005-10-19	2008-01-04	Urogene	Traitement de l'incontinence urinaire d'effort et mixte
FR2892022B1 (fr) *	2005-10-19	2008-01-04	Urogene Sa	Traitement des symptomes de l'irritation de la vessie
US8420593B1 (en) *	2006-06-16	2013-04-16	Landon C. G. Miller	Compositions and methods for regulating membrane potential
DE102008044844B4 (de) *	2008-08-28	2018-08-30	Siemens Healthcare Gmbh	Verfahren zur Ermittlung einer Schwächungskarte zur Verwendung in der Positronenemissionstomographie und von Homogenitätsinformationen des Magnetresonanzmagnetfeldes
WO2011118364A1 (en) *	2010-03-26	2011-09-29	Semiconductor Energy Laboratory Co., Ltd.	Semiconductor device
US20130184316A1 (en) *	2010-07-15	2013-07-18	Andrew Hornstein	Methods for diagnosing and treating concussive disorders
BR112013019265A2 (pt) *	2011-01-28	2016-10-11	Acorda Therapeutics Inc	uso de bloqueadores do canal de potássio no tratamento da paralisia cerebral
TWI592156B (zh) *	2011-10-04	2017-07-21	艾可達醫療公司	使用胺基吡啶以治療與中風有關之感覺動作損傷之方法
WO2017151409A1 (en)	2016-02-29	2017-09-08	University Of Florida Research Foundation, Incorporated	Chemotherapeutic methods
EP3727587A4 (en) *	2017-12-22	2022-02-23	Massachusetts Institute Of Technology	COMPOSITIONS AND METHODS FOR THERAPY OF WILLIAMS SYNDROME (WS)
WO2022159086A1 (en) *	2021-01-20	2022-07-28	Rush University Medical Center	Improved treatment for globoid cell leukodsytrophy or krabbe disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4880822A (en) *	1987-04-24	1989-11-14	Hoechst-Roussel Pharmaceuticals, Inc.	N-(pyridinyl)-1H-indol-1-amines
EP0287982B1 (en) *	1987-04-24	1994-12-07	Hoechst-Roussel Pharmaceuticals Incorporated	N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments
US4970218A (en) *	1987-04-24	1990-11-13	Hoechst-Roussel Pharmaceuticals Inc.	N-(pyridinyl)-1H-indol-1-amines
ES2068294T3 (es) *	1989-08-02	1995-04-16	Hoechst Roussel Pharma	2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos.
US5214038A (en) *	1991-04-15	1993-05-25	Hoechst-Roussel Pharmaceuticals Inc.	1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
DE4325491A1 (de) *	1993-07-29	1995-02-02	Boehringer Ingelheim Kg	Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
US5459274A (en) *	1994-05-13	1995-10-17	Hoechst-Roussel Pharmaceuticals Inc.	Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
US5565475A (en)	1994-11-08	1996-10-15	Muhlhauser; Mark A.	Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
EP0731108A1 (en)	1995-03-10	1996-09-11	Boehringer Mannheim Gmbh	Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes
FR2754147B1 (fr)	1996-10-03	2000-02-04	Mbh Technologies Sa	Installation et procede pour le traitement de carcasses
JP2002501926A (ja) *	1998-01-29	2002-01-22	ブリストル−マイヤーズスクイブカンパニー	ジアリール１、３、４−オキサジアゾロンのホスフェート誘導体
WO2001004091A1 (en)	1999-07-09	2001-01-18	Ortho-Mcneil Pharmaceutical, Inc.	Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
GB0119435D0 (en) *	2001-02-15	2001-10-03	Aventis Pharm Prod Inc	Method of treating of demyelinating diseases or conditions

2001
- 2001-08-09 GB GBGB0119435.6A patent/GB0119435D0/en not_active Ceased
2002
- 2002-02-14 CA CA002438712A patent/CA2438712A1/en not_active Abandoned
- 2002-02-14 NZ NZ527011A patent/NZ527011A/en unknown
- 2002-02-14 HU HU0303203A patent/HUP0303203A3/hu unknown
- 2002-02-14 EP EP02714974A patent/EP1368031A2/en not_active Withdrawn
- 2002-02-14 WO PCT/US2002/005501 patent/WO2002064126A2/en not_active Ceased
- 2002-02-14 BR BR0207272-6A patent/BR0207272A/pt not_active IP Right Cessation
- 2002-02-14 TR TR2008/00691T patent/TR200800691T2/xx unknown
- 2002-02-14 TR TR2008/00692T patent/TR200800692T2/xx unknown
- 2002-02-14 CZ CZ20032172A patent/CZ20032172A3/cs unknown
- 2002-02-14 CN CNA028048644A patent/CN1529598A/zh active Pending
- 2002-02-14 AP APAP/P/2003/002834A patent/AP1749A/en active
- 2002-02-14 NZ NZ556697A patent/NZ556697A/en unknown
- 2002-02-14 UA UA2003098376A patent/UA80394C2/uk unknown
- 2002-02-14 SG SG200505802-9A patent/SG134170A1/en unknown
- 2002-02-14 EA EA200600896A patent/EA012409B1/ru not_active IP Right Cessation
- 2002-02-14 KR KR1020087031854A patent/KR20090005254A/ko not_active Ceased
- 2002-02-14 SK SK1039-2003A patent/SK10392003A3/sk unknown
- 2002-02-14 NZ NZ544720A patent/NZ544720A/en unknown
- 2002-02-14 MX MXPA03006110A patent/MXPA03006110A/es active IP Right Grant
- 2002-02-14 KR KR1020037010691A patent/KR100951540B1/ko not_active Expired - Fee Related
- 2002-02-14 PL PL02363638A patent/PL363638A1/xx not_active Application Discontinuation
- 2002-02-14 IL IL15734102A patent/IL157341A0/xx unknown
- 2002-02-14 HR HR20030652A patent/HRP20030652A2/hr not_active Application Discontinuation
- 2002-02-14 TR TR2008/00693T patent/TR200800693T2/xx unknown
- 2002-02-14 CN CNB2005100597348A patent/CN100522164C/zh not_active Expired - Fee Related
- 2002-02-14 AU AU2002247200A patent/AU2002247200B9/en not_active Ceased
- 2002-02-14 TR TR2003/01330T patent/TR200301330T2/xx unknown
- 2002-02-14 EE EEP200300363A patent/EE200300363A/xx unknown
- 2002-02-14 NZ NZ539159A patent/NZ539159A/en unknown
- 2002-02-14 KR KR1020087031855A patent/KR100951542B1/ko not_active Expired - Fee Related
- 2002-02-14 YU YU62903A patent/YU62903A/sh unknown
- 2002-02-14 US US10/076,191 patent/US6967210B2/en not_active Expired - Lifetime
- 2002-02-14 EA EA200300882A patent/EA011319B1/ru not_active IP Right Cessation
- 2002-02-14 ME MEP-212/08A patent/MEP21208A/xx unknown
- 2002-02-14 JP JP2002563920A patent/JP2004518711A/ja not_active Ceased
- 2002-02-14 OA OA1200300199A patent/OA12549A/en unknown
- 2002-02-15 AR ARP020100540A patent/AR035750A1/es unknown
- 2002-02-15 TW TW091102861A patent/TWI325319B/zh not_active IP Right Cessation
- 2002-02-15 MY MYPI20020518A patent/MY157745A/en unknown
- 2002-02-15 CO CO02013025A patent/CO5390085A1/es not_active Application Discontinuation
- 2002-02-15 EC EC2002004218A patent/ECSP024218A/es unknown
- 2002-02-18 PA PA20028540101A patent/PA8540101A1/es unknown
- 2002-02-26 PE PE2002000159A patent/PE20040175A1/es not_active Application Discontinuation
2003
- 2003-07-11 MA MA27235A patent/MA26152A1/fr unknown
- 2003-07-16 CR CR7023A patent/CR7023A/es unknown
- 2003-08-07 ZA ZA200306124A patent/ZA200306124B/xx unknown
- 2003-08-11 IL IL157341A patent/IL157341A/en not_active IP Right Cessation
- 2003-08-14 NO NO20033622A patent/NO20033622L/no not_active Application Discontinuation
2004
- 2004-02-03 US US10/770,656 patent/US20040157889A1/en not_active Abandoned
- 2004-02-03 US US10/770,655 patent/US20040157888A1/en not_active Abandoned
2005
- 2005-03-14 US US11/079,366 patent/US7179821B2/en not_active Expired - Lifetime
- 2005-03-14 US US11/079,327 patent/US7230015B2/en not_active Expired - Lifetime
- 2005-09-27 US US11/236,145 patent/US7534803B2/en not_active Expired - Fee Related
2006
- 2006-01-05 HK HK06100186.8A patent/HK1080361B/zh not_active IP Right Cessation
- 2006-04-04 UA UAA200603708A patent/UA88773C2/ru unknown
2008
- 2008-03-13 AU AU2008201179A patent/AU2008201179B2/en not_active Ceased
2009
- 2009-04-06 JP JP2009091807A patent/JP2009185045A/ja not_active Abandoned
- 2009-04-29 US US12/420,390 patent/US20090281147A1/en not_active Abandoned
- 2009-04-29 US US12/420,381 patent/US20090270458A1/en not_active Abandoned
- 2009-04-29 US US12/420,407 patent/US20090209594A1/en not_active Abandoned
- 2009-04-29 US US12/420,416 patent/US20090209595A1/en not_active Abandoned
- 2009-11-19 AU AU2009238332A patent/AU2009238332A1/en not_active Abandoned
2010
- 2010-02-16 JP JP2010030929A patent/JP2010120958A/ja not_active Abandoned

Also Published As

Publication number	Publication date
JP2004518711A (ja)	2004-06-24
WO2002064126A3 (en)	2003-02-20
IL157341A0 (en)	2004-02-19
ECSP024218A (es)	2003-09-24
US20050234105A1 (en)	2005-10-20
US20040157888A1 (en)	2004-08-12
AU2002247200B2 (en)	2007-12-13
US6967210B2 (en)	2005-11-22
HUP0303203A3 (en)	2007-11-28
CZ20032172A3 (cs)	2004-01-14
TR200301330T2 (tr)	2004-12-21
EA200600896A1 (ru)	2006-08-25
GB0119435D0 (en)	2001-10-03
AP1749A (en)	2007-06-13
AU2009238332A1 (en)	2009-12-10
PL363638A1 (en)	2004-11-29
AU2002247200B9 (en)	2008-07-10
US7230015B2 (en)	2007-06-12
US20090270458A1 (en)	2009-10-29
MY157745A (en)	2016-07-15
TR200800692T2 (tr)	2008-03-21
TR200800693T2 (tr)	2008-07-21
HRP20030652A2 (en)	2005-06-30
EA012409B1 (ru)	2009-10-30
NO20033622D0 (no)	2003-08-14
NZ544720A (en)	2007-08-31
AP2003002834A0 (en)	2003-09-30
AU2008201179B2 (en)	2009-08-20
HUP0303203A2 (hu)	2003-12-29
WO2002064126A2 (en)	2002-08-22
PA8540101A1 (es)	2003-09-05
US20040157889A1 (en)	2004-08-12
CO5390085A1 (es)	2004-04-30
US20090209595A1 (en)	2009-08-20
KR100951542B1 (ko)	2010-04-09
TR200800691T2 (tr)	2008-03-21
US20090281147A1 (en)	2009-11-12
NZ539159A (en)	2006-11-30
CN1529598A (zh)	2004-09-15
CN1679564A (zh)	2005-10-12
BR0207272A (pt)	2004-02-10
US7179821B2 (en)	2007-02-20
PE20040175A1 (es)	2004-03-29
YU62903A (sh)	2006-05-25
AU2008201179A1 (en)	2008-04-03
NZ527011A (en)	2005-07-29
EE200300363A (et)	2003-10-15
KR20090005254A (ko)	2009-01-12
UA88773C2 (ru)	2009-11-25
KR100951540B1 (ko)	2010-04-09
KR20090005255A (ko)	2009-01-12
HK1080361A1 (zh)	2006-04-28
CA2438712A1 (en)	2002-08-22
MXPA03006110A (es)	2005-07-01
UA80394C2 (en)	2007-09-25
JP2010120958A (ja)	2010-06-03
SG134170A1 (en)	2007-08-29
MA26152A1 (fr)	2004-07-01
US20060025452A1 (en)	2006-02-02
IL157341A (en)	2010-11-30
NZ556697A (en)	2009-01-31
KR20040014459A (ko)	2004-02-14
EA200300882A1 (ru)	2003-12-25
JP2009185045A (ja)	2009-08-20
MEP21208A (en)	2010-06-10
US20090209594A1 (en)	2009-08-20
HK1080361B (zh)	2009-10-30
EP1368031A2 (en)	2003-12-10
EA011319B1 (ru)	2009-02-27
NO20033622L (no)	2003-10-06
AR035750A1 (es)	2004-07-07
CR7023A (es)	2003-11-17
CN100522164C (zh)	2009-08-05
SK10392003A3 (sk)	2004-01-08
TWI325319B (en)	2010-06-01
OA12549A (en)	2006-06-05
US20030105150A1 (en)	2003-06-05
US7534803B2 (en)	2009-05-19
US20050159456A1 (en)	2005-07-21

Publication	Publication Date	Title
AU2002332430A1 (en)	2003-02-17	Methods of treating neuropilin-mediated diseases
GB2393202B (en)	2005-12-21	Methods of well treatment
AU2002348135A1 (en)	2003-05-12	Methods for the treatment of addiction
HUP0302739A3 (en)	2012-09-28	Method for the treatment of tobacco
ZA200108446B (en)	2003-08-27	Novel method of treatment.
ZA200306124B (en)	2004-11-08	Method of treating of demyelinating diseases or conditions.
GB0129976D0 (en)	2002-02-06	Treatment method
EP1404339A4 (en)	2004-08-25	METHOD FOR TREATING FIBROTIC DISEASES OR OTHER INDICATIONS VI
EP1450820A4 (en)	2009-02-18	METHOD OF TREATING AND PREVENTING INFLAMMATORY DISEASES
GB2389532B (en)	2004-10-27	The method of treating cancer
AU2002229986A1 (en)	2002-09-04	Method of treating neurological diseases
AUPR731901A0 (en)	2001-09-20	Method of treatment
GB0120147D0 (en)	2001-10-10	Treatment method
GB0112216D0 (en)	2001-07-11	Method of treatment
GB0118892D0 (en)	2001-09-26	Method of treatment
AUPR381601A0 (en)	2001-04-12	Method of treating respiratory conditions
IL161630A0 (en)	2004-09-27	Methods of treating endometreosis
GB0126253D0 (en)	2002-01-02	Treatment method
GB0105703D0 (en)	2001-04-25	Method of animal treatment
GB0126094D0 (en)	2001-12-19	Method of treatment
GB0116029D0 (en)	2001-08-22	Method of treatment
GB0125105D0 (en)	2001-12-12	Method of treatment
GB0111487D0 (en)	2001-07-04	Method of treatment
AU2002257731A1 (en)	2002-10-15	Method of well treatment
GB0102927D0 (en)	2001-03-21	Treatment method